Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie E Weiss

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Neuro-Oncology|May 6, 2020
Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV GliomasDenise Bernhardt, Wolfgang Wick, Stephanie E Weiss, et al.
Neuro-Oncology|April 27, 2017
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based studyDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastomaJan Drappatz, Andrew D Norden, Eric T Wong, et al.
Neuro-Oncology|April 25, 2007
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adultsSantosh Kesari, David Schiff, Lisa Doherty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 6, 2018
Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiationDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.
Journal of Neuro-Oncology|July 26, 2014
Local control after fractionated stereotactic radiation therapy for brain metastasesSelvan Rajakesari, Nils D Arvold, Rachel B Jimenez, et al.
Neuro-Oncology|June 4, 2014
Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningiomaAyal A Aizer, Nils D Arvold, Paul Catalano, et al.
Practical Radiation Oncology|July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice GuidelineLia M Halasz, Albert Attia, Lisa Bradfield, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2019
Nodular Leptomeningeal Disease-A Distinct Pattern of Recurrence After Postresection Stereotactic Radiosurgery for Brain Metastases: A Multi-institutional Study of Interobserver ReliabilityBrandon E Turner, Roshan S Prabhu, Stuart H Burri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsEudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Neuro-Oncology|May 6, 2020
Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV GliomasDenise Bernhardt, Wolfgang Wick, Stephanie E Weiss, et al.
Neuro-Oncology|April 27, 2017
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based studyDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastomaJan Drappatz, Andrew D Norden, Eric T Wong, et al.
Neuro-Oncology|April 25, 2007
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adultsSantosh Kesari, David Schiff, Lisa Doherty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 6, 2018
Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiationDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.
Journal of Neuro-Oncology|July 26, 2014
Local control after fractionated stereotactic radiation therapy for brain metastasesSelvan Rajakesari, Nils D Arvold, Rachel B Jimenez, et al.
Neuro-Oncology|June 4, 2014
Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningiomaAyal A Aizer, Nils D Arvold, Paul Catalano, et al.
Practical Radiation Oncology|July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice GuidelineLia M Halasz, Albert Attia, Lisa Bradfield, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2019
Nodular Leptomeningeal Disease-A Distinct Pattern of Recurrence After Postresection Stereotactic Radiosurgery for Brain Metastases: A Multi-institutional Study of Interobserver ReliabilityBrandon E Turner, Roshan S Prabhu, Stuart H Burri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsEudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Pageof 4